Cochlear Limited (OTCMKTS:CHEOY - Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 800 shares, a growth of 60.0% from the September 15th total of 500 shares. Based on an average trading volume of 7,600 shares, the days-to-cover ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada upgraded Cochlear to a "hold" rating in a report on Friday, August 16th.
Read Our Latest Stock Analysis on Cochlear
Cochlear Stock Up 2.9 %
OTCMKTS:CHEOY traded up $2.80 during mid-day trading on Friday, hitting $100.64. The stock had a trading volume of 10,608 shares, compared to its average volume of 3,916. Cochlear has a twelve month low of $76.12 and a twelve month high of $115.85. The stock has a 50-day simple moving average of $101.10 and a two-hundred day simple moving average of $105.55.
Cochlear Increases Dividend
The company also recently disclosed a dividend, which will be paid on Friday, October 25th. Stockholders of record on Wednesday, September 18th will be issued a $0.1424 dividend. This is a positive change from Cochlear's previous dividend of $0.03. The ex-dividend date of this dividend is Wednesday, September 18th.
Cochlear Company Profile
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
Before you consider Cochlear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cochlear wasn't on the list.
While Cochlear currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.